netFormulary NHS
Isle of Wight
Formulary
 Search
 Formulary Chapter 4: Central nervous system - Full Section
Numbers in brackets indicate counts of (Formulary items, Non Formulary items)
04.01 Hypnotics and anxiolytics (0,0)
04.01.01 Hypnotics (1,0)
Benzodiazepines (2,0)
Zaleplon, Zolpidem and Zopiclone (2,0)
Antihistamines (1,0)
04.01.02 Anxiolytics (0,0)
Benzodiazepines (2,0)
Buspirone (1,0)
Beta blockers (1,0)
04.02 Drugs used in psychoses and related disorders (0,0)
04.02.01 Antipsychotic Drugs (0,0)
First-Generation Antipsychotic Drugs (FGAs) - Oral administraion (6,0)
Second-Generation Antipsychotic Drugs (SGAs) - Oral Administration (7,0)
04.02.02 Antipsychotic depot injections (9,0)
04.02.03 Drugs used for mania and hypomania (0,0)
Benzodiazepines (0,0)
Antipsychotic drugs (3,0)
Carbamazepine (0,0)
Valproic acid (1,0)
Lithium (2,0)
04.03 Antidepressant drugs (0,0)
04.03.01 Tricyclic and related antidepressant drugs (0,0)
Tricyclic antidepressants (5,0)
04.03.02 Monoamine-oxidase inhibitors (0,0)
04.03.03 Selective serotonin re-uptake inhibitors (5,0)
04.03.04 Other antidepressant drugs (5,0)
04.04 CNS stimulants and other drugs used for attention deficit hyperactivity disorder (5,0)
04.05 Drugs used in the treatment of obesity (0,0)
04.06 Drugs used in nausea and vertigo (12,0)
Phenothiazines and related drugs (0,0)
5HT3 antagonists (0,0)
04.07 Analgesics (0,0)
04.07.01 Non-opioid analgesics and compound analgesic preparations (3,0)
Compound analgesic preparations (2,0)
04.07.02 Opioid analgesics (15,0)
04.07.03 Neuropathic pain (5,0)
Trigeminal neuralgia (1,0)
Postherpetic neuralgia (1,0)
04.07.04 Antimigraine drugs (0,0)
04.07.04.01 Treatment of the acute migraine attack (0,0)
Analgesics (1,0)
5HT1 agonists (5,0)
04.07.04.02 Prophylaxis of migraine (4,0)
04.07.04.03 Cluster headache (2,0)
04.08 Antiepileptics (0,0)
04.08.01 Control of epilepsy (0,0)
Partial seizures with or without secondary generalisation (0,0)
Generalised seizures (0,0)
Carbamazepine and Oxcarbazepine (2,0)
Ethosuximide (0,0)
Gabapentin and pregabalin (2,0)
Lacosamide (1,0)
Lamotrigine (1,0)
Levetiracetam (1,0)
Perampanel (0,0)
Phenobarbital and other barbiturates (2,0)
Phenytoin (1,0)
Retigaine (0,0)
Rufinamide (0,0)
Rufinamide (0,0)
Tiagabine (0,0)
Topiramate (1,0)
Valproate (1,0)
Vigabatrin (1,0)
Zonisamide (1,0)
Benzodiazepines (2,0)
Other Drugs (0,0)
04.08.02 Drugs used in status epilepticus (5,0)
04.08.03 Febrile convulsions (1,0)
04.09 Drugs used in parkinsonism and related disorders (0,0)
04.09.01 Dopaminergic drugs used in Parkinsons disease (0,0)
Dopamine receptor agonists (5,0)
Levodopa (3,0)
Monoamine-oxidase-B inhibitors (2,0)
Catachol-O-methyltransferase inhibitors (1,0)
Amantadine (1,0)
04.09.02 Antimuscarinic drugs used in parkinsonism (3,0)
04.09.03 Drugs used in essential tremor, chorea, tics, and related disorders (3,0)
Torsion dystonias and other involuntary movements (0,0)
04.10 Drugs used in substance dependence (0,0)
Alcohol dependence (0,0)
Cigarette smoking (2,0)
Opioid dependence (0,0)
04.10.01 Alcohol dependence (5,0)
04.10.02 Nicotine dependence (1,0)
04.10.03 Opioid dependence (0,0)
Opioid substitution therapy (1,0)
Adjunctive therapy and symptomatic treatment (0,0)
Opioid-receptor antagonists (1,0)
04.11 Drugs for dementia (4,0)
netFormulary